<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-microorganisms-08-00963">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stone</surname>
    <given-names>V.M.</given-names>
   </name>
   <name>
    <surname>Hankaniemi</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Laitinen</surname>
    <given-names>O.H.</given-names>
   </name>
   <name>
    <surname>Sioofy-Khojine</surname>
    <given-names>A.B.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lozano</surname>
    <given-names>I.M.D.</given-names>
   </name>
   <name>
    <surname>Mazur</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Marjomäki</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Loré</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hyöty</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates</article-title>
  <source>Sci. Adv.</source>
  <year>2020</year>
  <volume>6</volume>
  <fpage>eaaz2433</fpage>
  <pub-id pub-id-type="doi">10.1126/sciadv.aaz2433</pub-id>
  <?supplied-pmid 32494709?>
  <pub-id pub-id-type="pmid">32494709</pub-id>
 </element-citation>
</ref>
